• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar

Davis+Gilbert LLP

From our base in New York, we represent a diverse range of clients across the country and around the world.

  • People
  • Services
  • Emerging Issues

RCT

The FTC’s “Reasonable Basis” Standard Has Evolved for Disease Efficacy Claims

January 9, 2019 by Megan O'Malley

The Bottom Line The FTC made it clear many times in 2018 that disease efficacy claims must be supported by competent and reliable scientific evidence, including human clinical testing, and that expert opinions will help guide the kind of human clinical testing and the number of RCTs that is Continue Reading

Alert - January 9, 2019

Primary Sidebar

  • Sitemap
  • Privacy Policy
  • Terms and Conditions
  • About Us
  • Subscribe
  • Location
© 2023 Copyright Davis+Gilbert LLP. Attorney Advertising.
  • People
  • Services
  • Emerging Issues
  • Insights + Events
  • Diversity, Equity + Inclusion
  • Pro Bono + Corporate Social Responsibility
  • Careers
  • About Us
  • Subscribe
  • Location